WASHINGTON, D.C. – U.S. Senator Cory Booker (D-NJ), a member of the Senate Judiciary Committee, issued the following statement in response to Donald Trump’s Executive Order on Cannabis rescheduling:
“After decades of ignoring the evidence, the federal government has finally come to terms with what a majority of states have long acknowledged cannabis has medical uses and a lower potential for abuse than drugs like methamphetamine and heroin. For too long, federal law has lagged behind medical and scientific research. Based on this research, the FDA recommended last year that cannabis be rescheduled as a Schedule III substance under the Controlled Substances Act. I am pleased that President Trump has directed the DOJ to complete the rulemaking process and implement this change.
“Rescheduling will provide tax relief for businesses operating legally in New Jersey. The change also opens the door for expanded scientific research, allowing medical professionals and institutions to study its potential benefits and risks with far fewer regulatory hurdles.
“However, rescheduling cannabis alone will not eliminate the harms of federal prohibition. Millions of Americans, especially Black and Brown communities, will continue to face criminal penalties for recreational use or for using medical marijuana products that lack federal approval. Thousands will remain in prisons around the country for marijuana-related offenses. Nor will this change restore access to public housing or nutrition assistance for people who use marijuana recreationally.
“While President Trump has moved to reclassify cannabis in accordance with scientific and medical evidence, his administration’s broader approach to marijuana stands in stark contrast. This administration continues to use marijuana offenses as pretext to detain and deport nonviolent immigrants. The Department of Justice rescinded enforcement guidance that had deprioritized charging low-level cannabis crimes, and President Trump just signed legislation that will recriminalize intoxicating hemp-derived substances. Meaningful cannabis reform must go beyond rescheduling to address systemic harms.
“With this announcement, we are moving one step closer to a common-sense, evidence-based approach to federal cannabis policy. I urge my colleagues in Congress to support the Cannabis Administration and Opportunity Act, which I will be reintroducing in the coming months. This bill would deschedule cannabis, establish a comprehensive regulatory and taxation system, and provide much-needed resources to communities most harmed by failed federal policies that prioritized criminalization over science, public health, and fairness.”
